Summary:
This is a 12 week, placebo-controlled, double-blind study in patients with IBS-D who report inadequate control of IBS-D symptoms with prior diarrhea medication. 5 office visits are required. These visits may include, physical exams, laboratory tests, IBS reporting, vital sign monitoring and questionnaires regarding IBS symptoms.
Qualified Participants Must:
• Be between 18 and 80 years of age
•
Have IBS-D or loose stools more than 25% of bowel movements
Qualified Participants May Receive:
Study participants will receive, study IBS-D medication, study exams, study labs and compensation at every completed visit.